Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell receptor alpha variable 15 (TRAV15) is a gene segment within the TCR alpha locus that encodes part of the variable domain of the TCR alpha chain. This segment participates in V(J) recombination during T cell development, contributing to the diversity and antigen specificity of αβ T cell receptors[2][3]. The TCR itself is a heterodimeric protein complex on T cells, responsible for recognizing antigenic peptides presented by major histocompatibility complex (MHC) molecules and initiating T cell activation and adaptive immune responses[1][3]. TRAV15 is one of many TRAV gene segments that can be selected during recombination, ultimately determining the antigen specificity and functionality of individual T cells. The clinical roles of TRAV15 are primarily associated with its contribution to immune repertoire diversity, and it is not considered a direct therapeutic target in current medical practice[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor alpha variable 15 (TRAV15).